Axxent® X-ray Source | Xoft | Elekta

Axxent® X-ray Source

Key component of Elekta Xoft

An integrated, radiation therapy platform solution

A miniaturized x-ray source delivers a precise dose of radiation directly to the cancerous site. This focused approach carefully destroys cancer cells and spares surrounding healthy tissue.

Benefits

New, improved cooling design allows long lasting performance over many more patients and many more fractions

High dose rate, low energy radiation offers excellent coverage to the target volume, with a sharper dose gradient than conventional HDR isotopes

Enables minimally-invasive IORT use in hard-to-reach areas using a long flexible source catheter

Increases patient confidence by allowing medical personnel to be present in room during treatment

Unlike isotopes, radiation is emitted only when the x-ray source is turned on during treatment

Available in 25 cm and 50 cm lengths for a broader range of treatment options

Elekta Xoft

Versatile, state of the art
x-ray technology

The versatile Elekta Xoft® Axxent® Electronic Brachytherapy (eBx®) System® utilizes state-of-the-art 50kV x-ray technology to provide expanded treatment options for a range of cancers.

Elekta Xoft provides isotope-free HDR therapeutic radiation of the disease target while sparing surrounding healthy tissue.

Elekta Xoft utilizes a proprietary, miniaturized x-ray tube with state-of-the-art extended source life cooling to apply radiation directly to the tumor site. The clear circulating cooling fluid is non-toxic, and effectively maintains proper tube temperature. The use of a high-performance, nonaqueous coolant extends source life dramatically.

The steep dose gradient of the 50kV source minimizes exposure to adjacent healthy tissues and organs and allows medical personnel to remain in the room with the patient in virtually any clinical setting with minimal shielding.

Combined with the comprehensive capabilities of Elekta Xoft, the x-ray source offers an attractive option to physicians and patients for improved flexibility, precision and personalization in the targeted treatment of cancer.

Elekta Xoft may not be available in all markets.

Indications currently under investigation include prostate, colorectal and brain cancers.

Axxent Products

Discover our Advanced, Multi-Platform System

Please consult with your Elekta Representative for availability of Xoft.